CPB heads into its June 8 earnings with a short position that has nearly doubled in six weeks and a borrow market tightening fast — a charged setup for a stock already trading near multi-year lows.
Short interest has climbed relentlessly. SI as a percentage of free float reached 27.5% on June 2, up from roughly 19.4% in late April — a 36% surge in shares short over the past month alone. That jump pushed CPB's short score to 76.7, a fresh high for the recent series and among the most elevated readings across the consumer staples universe. The ORTEX factor rank on short score sits in the 2nd percentile — meaning almost every comparable stock carries less short pressure. Days to cover on the official FINRA data run to 7.8 days, another measure of how crowded the position has become.
The borrow market confirms the urgency. Cost to borrow hit 6.3% on June 2 — more than four times the 1.5% level seen just a month ago, a 327% move in 30 days. Availability has tightened to 27%, the lowest reading of the past 52 weeks, down from above 60% as recently as early May. For every two shares currently borrowed, barely one more remains available to lend. That is a meaningful tightening in a very short window, and it tells you demand for short exposure has outpaced the supply of lendable stock. Options traders, by contrast, are not showing the same alarm — the put/call ratio is 0.66, essentially flat with its 20-day average of 0.66, showing almost no deviation. Short sellers are loading up; options traders are not hedging harder than usual.
The Street has turned decisively more cautious this week. Bernstein downgraded CPB to Underperform on June 3 and cut its target to $19 from $21. That follows UBS trimming its Sell target to $19 on June 2 and Stephens downgrading to Equal-Weight on June 1, cutting from $28 to $21. Evercore ISI also lowered its target to $24. Every analyst action in the past five days has been a cut or downgrade. The consensus sits at Hold with a mean price target near $22, roughly 5% above the current $20.99 close — thin upside given the severity of the negative momentum in analyst sentiment. EPS momentum ranks in the 27th percentile on a 30-day basis and the 15th percentile on a 90-day basis, confirming the Street has been trimming estimates for some time. The EV/EBITDA multiple of 8.4x has edged higher over the past month as earnings estimates fall faster than the share price.
One piece of institutional context worth noting: the Dorrance family — descendants of the founder and long the controlling shareholder bloc — held over 15% of shares as of last reported filings. A separate Dorrance family trust trimmed nearly 27 million shares in the most recent quarter. That reduction in a generational anchor position adds a layer of structural overhang to a stock already under pressure from short sellers and analysts alike.
The prior earnings print tells a stark story. CPB fell 12.3% on the day of its March 11 results and extended those losses to 14.6% over the following five days. That reaction is the most recent live data point the market has to price the June 8 release — and with short interest 37% higher now than it was heading into that print, the positioning into this week's number is even more extended.
What to watch Thursday is whether management can address the volume trend in meals and beverages that has driven the estimate-cut cycle — the stock's next move hinges less on whether Campbell's beats the headline number and more on whether guidance gives any reason for analysts running sub-$20 targets to revisit their thesis.
See the live data behind this article on ORTEX.
Open CPB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
